Y-mAbs Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Y-mAbs Therapeutics, Inc. reported Increase (Decrease) in Accounts Receivable of -$3.95 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was -$2.00M, a 224.77% decline year-over-year.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was -$1.95M.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-12-31 was $292.00K, a 91.84% decline year-over-year.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-09-30 was -$2.27M.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$2.25M, a 122.63% decline from fiscal 2023.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $9.92M, a 105.91% increase from fiscal 2022.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $4.82M, a 37.51% decline from fiscal 2021.
- Y-mAbs Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2021 was $7.71M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$3.95M 10-Q · filed 2025-08-08 | -$3.66M derived: sum of 3 quarters · filed 2025-08-08 | -$5.93M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$1.95M 10-Q · filed 2025-05-13 | -$1.66M derived: sum of 2 quarters · filed 2025-05-13 | -$3.93M derived: sum of 3 quarters · filed 2025-05-13 | -$2.33M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$1.98M derived: sum of 2 quarters · filed 2025-03-04 | -$380.00K derived: sum of 3 quarters · filed 2025-08-08 | -$2.25M 10-K · filed 2025-03-04 |
| 2024-09-30 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$672.00K derived: sum of 2 quarters · filed 2025-08-08 | -$2.54M 10-Q · filed 2024-11-08 | $1.04M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$263.00K 10-Q · filed 2025-08-08 | $3.32M derived: sum of 3 quarters · filed 2025-08-08 | $3.07M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$1.87M 10-Q · filed 2025-05-13 | $1.71M derived: sum of 2 quarters · filed 2025-05-13 | $1.47M derived: sum of 3 quarters · filed 2025-05-13 | $1.89M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $3.34M derived: sum of 2 quarters · filed 2025-03-04 | $3.75M derived: sum of 3 quarters · filed 2025-03-04 | $9.92M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $172.00K derived: sum of 2 quarters · filed 2024-11-08 | $6.34M 10-Q · filed 2024-11-08 | $9.62M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $6.59M 10-Q · filed 2024-08-12 | $9.87M derived: sum of 3 quarters · filed 2024-08-12 | $11.91M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $6.17M 10-Q · filed 2024-05-07 | $9.45M derived: sum of 2 quarters · filed 2024-05-07 | $11.49M derived: sum of 3 quarters · filed 2024-05-07 | $9.38M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.32M derived: sum of 2 quarters · filed 2024-02-29 | $3.21M derived: sum of 3 quarters · filed 2024-02-29 | $4.82M 10-K · filed 2024-02-29 |
| 2022-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$73.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.54M 10-Q · filed 2023-11-13 | $1.99M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$504.00K 10-Q · filed 2023-08-10 | -$56.00K derived: sum of 3 quarters · filed 2023-08-10 | -$1.31M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.61M 10-Q · filed 2023-05-08 | $2.06M derived: sum of 2 quarters · filed 2023-05-08 | $807.00K derived: sum of 3 quarters · filed 2023-05-08 | $3.33M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $448.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$805.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.72M derived: sum of 3 quarters · filed 2023-03-30 | $7.71M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.27M derived: sum of 2 quarters · filed 2022-11-07 | $7.26M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $8.52M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $6.00M 10-Q · filed 2022-05-09 |